BDBM50216389 CHEMBL231643::N-(2-(4-(4-cyanophenyl)piperazin-1-yl)-2-oxoethyl)isoquinoline-5-sulfonamide::isoquinolinesulfon-5-yl-{2-[4-(4-cyanophenyl)piperazin-1-yl]-2-oxoethyl}amide

SMILES O=C(CNS(=O)(=O)c1cccc2cnccc12)N1CCN(CC1)c1ccc(cc1)C#N

InChI Key InChIKey=ATAALHCGCBKUDG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50216389   

TargetP2X purinoceptor 7(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50216389(CHEMBL231643 | N-(2-(4-(4-cyanophenyl)piperazin-1-...)
Affinity DataIC50: >1.00E+3nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium influxMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2X purinoceptor 7(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50216389(CHEMBL231643 | N-(2-(4-(4-cyanophenyl)piperazin-1-...)
Affinity DataIC50: >1.00E+3nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as effect on intracellular calcium influxMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed